Recent Advances in Endothelial Progenitor Cells Toward Their Use in Clinical Translation

Since the discovery of Endothelial Progenitor Cells (EPC) by Asahara and colleagues in 1997, an increasing number of preclinical studies have shown that EPC based therapy is feasible, safe, and efficacious in multiple disease states. Subsequently, this has led to several, mainly early phase, clinica...

Descripción completa

Detalles Bibliográficos
Autores principales: Keighron, Cameron, Lyons, Caomhán J., Creane, Michael, O'Brien, Timothy, Liew, Aaron
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6305310/
https://www.ncbi.nlm.nih.gov/pubmed/30619864
http://dx.doi.org/10.3389/fmed.2018.00354

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6305310/
https://www.ncbi.nlm.nih.gov/pubmed/30619864
http://dx.doi.org/10.3389/fmed.2018.00354

Ejemplares similares